Ocular Therapeutix (OCUL) Tops Q2 EPS by 3c

Ocular Therapeutix (NASDAQ: OCUL) reported Q2 EPS of ($0.46), $0.03 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.

You May Also Be Interested In

• Helen of Troy (HELE) Tops Q1 EPS by 22c, Beats on Revenue; Offers FY Guidance
• Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook
• Penguin Solutions (PENG) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY26 EPS Guidance